Gsk (GSK) Net Cash Flow Growth (5y) (2014 - 2026)
Powered by 
Analysis
Gsk (GSK) Net Cash Flow Growth (5y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Asml Holding | 618.86 Bn | 602.88 Bn | 5.90 Bn |
| 2 | Hsbc Holdings | 361.40 Bn | 361.40 Bn | - |
| 3 | General Electric | 329.38 Bn | 320.03 Bn | 6.95 Bn |
| 4 | Astrazeneca | 253.73 Bn | 248.44 Bn | 12.86 Bn |
| 5 | Citigroup | 228.07 Bn | -2,074.24 Bn | 24.75 Bn |
| 6 | Bhp | 216.09 Bn | 197.55 Bn | - |
| 7 | Rio Tinto | 203.71 Bn | 199.33 Bn | - |
| 8 | Diageo | 197.36 Bn | 195.32 Bn | - |
| 9 | Unilever | 139.15 Bn | 132.12 Bn | - |
| 10 | Gsk | 101.53 Bn | 101.53 Bn | 15.97 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22.83% |
| Mar 31, 2026 | 45.65% |
| Dec 31, 2025 | 19.67% |
| Sep 30, 2025 | -23.57% |
| Jun 30, 2025 | 4.63% |
| Mar 31, 2025 | 50.89% |
| Dec 31, 2024 | -5.32% |
| Sep 30, 2024 | 35.35% |
| Jun 30, 2024 | 0.36% |
| Mar 31, 2024 | -21.59% |
| Dec 31, 2023 | -3.91% |
| Sep 30, 2023 | 12.59% |
| Jun 30, 2023 | 2.22% |
| Mar 31, 2023 | -16.42% |
| Dec 31, 2022 | -25.30% |
| Sep 30, 2022 | -1.15% |
| Jun 30, 2022 | 10.18% |
| Mar 31, 2022 | -38.88% |
| Dec 31, 2021 | -45.48% |
| Sep 30, 2021 | 17.57% |